甲基受体-1 (FPR1) 抑制肠道瘤发生
Julie Le Naour1,2,3, Léa Montégut1,2,3, Yuhong Pan1,2,4
1Centre de Recherche des Cordeliers, Equipe Labellisée Par la Ligue Contre le Cancer, Université Paris Cité, Sorbonne Université, Inserm U1138, Institut Universitaire de France, Paris, France.
Oncoimmunology
|July 26, 2023
概括
在骨髓细胞中缺陷的甲基受体-1 (FPR1) 信号损害了抗瘤免疫力,增加了小鼠对结直肠癌和结肠炎的易感性. 这突显了FPR1的地位.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
背景情况:
- 甲基受体-1 (FPR1) 是一种涉及免疫反应的髓状细胞受体.
- 在FPR1中的功能丧失多态性与治疗结果差以及结直肠癌 (CRC) 中的加速致癌有关.
- 在肠道瘤发生和炎症性肠病中FPR1的作用仍然不完全理解.
研究的目的:
- 调查甲基受体-1 (FPR1) 在结直肠癌 (CRC) 发展和进展中的作用.
- 确定FPR1缺乏对先天性免疫细胞功能和易受化学诱导大肠炎和瘤发生的影响.
主要方法:
- 使用了Fpr1淘汰 (Fpr1-/-) 小鼠和野生类型的产卵对照.
- 评估了树突细胞迁移对化疗治疗的CRC细胞的反应.
- 诱导性慢性性结肠炎和结肠直肠瘤发生,使用阿佐西米和德克斯硫酸盐在Fpr1-/-小鼠.
- 研究了药理性FPR1抑制 (环素H) 和抗炎药物苏林达克在ApcMin小鼠中的作用.
主要成果:
- 来自Fpr1-/-小鼠的树突细胞向化疗治疗的CRC细胞的迁移减少.
- Fpr1-/-小鼠对阿佐西甲/德克斯硫酸诱导的大肠炎和结肠直肠瘤发生的敏感性增加.
- 药理上抑制FPR1倾向于在ApcMin小鼠中促进肠道瘤发生,这种效应被sulindac.c.逆转.
结论:
- 缺陷的FPR1信号加剧了肠道瘤发生,可能是通过损害先天的炎症和免疫反应.
- FPR1在宿主防御大肠炎和结肠直肠癌发展方面发挥着关键作用.
- 向FPR1可能为结直肠癌和炎症性肠道疾病提供治疗策略.
相关概念视频
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.2K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.2K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Role Of Notch Signalling In Intestinal Stem Cell Renewal
2.1K
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.1K
NF-κB-dependent Signaling Pathway
7.5K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.5K
Transducer Mechanism: G Protein–Coupled Receptors
2.1K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
2.1K


